|
Indian Pediatr 2017;54:461-466 |
 |
Components of Metabolic
Syndrome at 22 years of Age – Findings From Pune Low Birth
Weight Study
|
Sudha Chaudhari, Madhumati Otiv, Mahendra Hoge, Anand
Pandit and Mohammed Sayyed
From Department of Pediatrics, King Edward Memorial
Hospital Research Centre, Pune, Maharashtra, India.
Correspondence to: Dr Sudha Chaudhari, Consultant,
Division of Neonatology, Department of Pediatrics, KEM Hospital Research
Centre, Pune 411 011. Maharashtra, India.
Email: [email protected]
Received: January 08, 2016;
Initial review: March 21, 2016;
Accepted: March 30, 2017.
|
Objective: To study the early markers of Metabolic syndrome in a
cohort of low birth weight (LBW) children followed up since birth, at
the age of 22 years.
Design: Prospective cohort study.
Setting: Tertiary-care hospital
Participants: Neonates weighing less than 2000 g
discharged from a neonatal special care unit were followed up
prospectively; 153 cases and 77 controls were assessed at 22 years of
age.
Methods: Fasting, 30 minute and 120 minute
glucose and insulin after a bolus of 75g of glucose was determined.
Insulin resistance was calculated. A lipid profile was also done.
Anthropometric measurements were taken and abdominal fat was determined
by magnetic resonance imaging.
Main outcome: Prevalence of the five components
of Metabolic Syndrome as described by the International Diabetic
Federation (IDF).
Results: 65.1% of the cohort was born small for
gestational age. All three components of Metabolic syndrome were present
in only three cases and none of the controls. However, two components
were present in 25 (16.4%) cases and 5 (6%) controls (P=0.039).
Cases in the lowest quartile of birthweight who became big at 22 years
had significantly higher fasting insulin (P=0.001), Homeostatic
Model Assessment – Insulin Resistance (Homa-IR) (P=0.001) and
higher systolic blood pressure. Sum of skinfold thickness at 4 sites
correlated significantly with fasting insulin and HOMA-IR, and was a
stronger correlate compared to BMI, waist circumference and MRI fat.
There was no difference in the biochemical parameters between
appropriate for gestational age and small for gestational age infants.
Conclusion: Prevalence of three or more
components of Metabolic syndrome was low in LBW children at 22 years,
but of two components was high. Those ‘Small at birth and big at 22
years’ had high insulin resistance.
Keywords: Hypertension, Insulin resistance, Outcome,
Triglycerides.
|
I ndia is experiencing an epidemic of type II
diabetes and coronary heart disease (CHD) in young adults and
middle-aged population [1]. The cluster of risk factors of CHD, type II
diabetes, hypertension and central obesity is known as the Metabolic
syndrome. Nutritional deprivation of the fetus during critical periods
of development leads to adaptive survival strategies [2], leading to
increased susceptibility to adult-onset coronary heart disease and type
II diabetes [3,4]. We have been following a cohort of low birth weight
(<2000 g) along with normal birth weight controls since their birth for
the past 22 years - "Pune low birth weight study – birth to adulthood"
[5,6]. In this study, we report the occurrence of various components of
metabolic syndrome in this cohort.
Methods
The cohort consisted of infants weighing <2000 g,
discharged from a neonatal special care unit between October 1987 to
April 1989, and followed up prospectively till the age of 18 years [5].
The LBW infants were classified into appropriate for gestational age
(AGA) or small for gestational age (SGA) using the criteria of Singh,
et al. [7]. Full term neonates born in the same hospital during the
same period with birth weight ³2500g
with a normal antenatal, natal and postnatal course, matched for
socio-economic status were enrolled as controls. The parents were
offered a free check-up as an added incentive. Ethical permission was
obtained from the hospital’s Ethics Committee. Written informed consent
of both the parents and subjects was obtained at the time of enrolment
in the 22 year study.
Infants and parents were examined by the medical
officer and questioned regarding any major illness in the past and
recent medical problems. Blood pressure was measured with a standard
sphygmomanometer by the medical officer. The mean of three readings of
systolic and diastolic pressure was recorded. Hypertension was defined
as systolic pressure above 130 mm Hg, and diastolic pressure above 85
mmHg. After an overnight fast, oral Glucose tolerance test was done. A
fasting blood sample was collected, and 30 and 120 minute samples were
collected after glucose administration. Lipid profile, consisting of
total cholesterol, LDL, VLDL, HDL and triglycerides, was measured
(enzymatic method). Insulin was measured by Delfia technique and ELISA.
Homeostatic Model Assessment – Insulin Resistance (Homa-IR) was
calculated using the online Oxford model (http://www.dtu.ox.ac.uk).
Weight was measured by an electronic scale with an
accuracy of ±10g. Standing and sitting height was measured to the
nearest 0.5 cm by a wall-mounted stadiometer using the standard
technique, described by Tanner [8]. BMI was calculated and categorized.
Waist circumference was measured by a non-stretchable tape to the
nearest 0.1 cm midway between the lower costal margin and superior iliac
crest in expiration. Hip circumference was measured at the point of
maximum protuberance. Skin fold thickness was measured at 4 sites –
biceps, triceps, subscapular and suprailiac, using Harpender’s caliper.
Dietary intake was assessed by 24- hour diet recall (weekday and
weekend) and validated food frequency questionnaire [9]. Physical
activity was assessed by using a questionnaire and BMR; physical
activity level (PAL) was calculated using physical activity ratio (PAR)
values of each activity in 24 hours [10].
Magnetic resonance imaging (MRI) of abdomen was
performed on a 1.5 Tesla unit (GE 16 Channel HD, T, USA). Axial T 1,
weighted spoiled gradient echo sequence without fat suppression was used
to scan the patients from xiphisternum to pubic symphysis (Repetition
time 100 msec, Echo time – 1.2 msec, slice thickness – 10 mm, interval 1
mms). Two markings were done at each axial, one on the outer edge of
abdominal wall muscles and second at the outermost edge of subcutaneous
fat. Values of inner marking were subtracted from that of the outer
marking to derive the subcutaneous fat content in the abdominal wall.
All these values were added and divided by the number of sections from
xiphisternum to pubic symphysis [11].
Female participants were questioned regarding
menstruation history and present status, and were examined for hirsutism.
Pelvic ultrasonography was done (Aloka SSB 3500 machine) with a 2–5
megahertz convex sector on the 3 rd
to 5th day of menstruation.
Polycystic ovarian disease was diagnosed if there were bilateral
enlarged ovaries with increased stromal echogenicity with multiple
peripheral follicles. Polycysitc ovary syndrome was diagnosed if there
was evidence of hyper-androgenism and ovarian dysfunction, menstural
cycle >35 days and/or polycystic ovaries [12].
The Internataional Diabetic Federation [13] lists
five components of the metabolic syndrome for Asian population. A
diagnosis of metabolic syndrome can be made if three components out of
the five are present: (i) Waist circumference
³90 cm in men and
³80 cm in
women; (ii) Serum triglycerides
³150 mg/dL (1.7 mmol/L);
(iii) Fasting glucose ³110mg/dL
(6.1 mmol/L) (iv) Blood pressure
³130/80 mmHg; and (v)
High density lipoprotein <40
mg/dL (1.03 mmol/L) in men and <50 mg/dL (1.29 mmol/L) in women.
Statistical analysis: For the variables
not normally distributed, appropriate transformations for the underlying
normality assumption are used. The linear association between the
normally distributed variables was assessed by Pearson’s correlation
coefficients; otherwise Spearman’s correlation coefficients were used.
The partial correlation analysis was also used to test the independent
associations between several variables of interest. The factors such as
sex, socio-economic status and current BMI were used as confounders for
most of the correlation analysis.
The LBW cases and the control groups were first
compared by using independent sample ‘t’ test for quantitative
variables. Simple Chi-square test or Fisher’s exact test for
independence of attributes was used to explore the differences between
the groups in the prevalence of specific components of metabolic
syndrome.
For finding the independent predictors of a few
quantitative variables such as 120-min glucose and systolic BP, the
multivariate analysis was carried out by multiple linear regression
technique. The adjusted R 2
was used to determine the predictive power of the model fitted. The
statistical significance for the entire analyses was set at P<0.05
level. All statistical analyses was performed using Statistical Package
for Social Science (SPSS) for Windows (version 11.5).
Results
We have previously described the growth and cognitive
development of 161 LBW infants at 18 years [5,6]. There was a dropout of
8 LBW subjects at 22 years, and hence 153 LBW and 77 normal controls
were studied. The birth weight of the study group ranged from 866 g to
1999 g with a mean (SD) of 1545.5 (243.9) g and the mean (SD) birth
weight of the control group was 2835.0 (305.8) g. There were 93 (60.8%)
males and 60 (39.2%) females in the LBW group and 45 (58.4%) males and
32 (41.1%) females in the control group. There were 60 (39.2%) preterm
SGA, 38 (24.8%) full term SGA and 55 (35.9%) preterm AGA babies in the
LBW cohort. The comparison of the anthropometric measurements and
biochemical parameters and MRI fat between cases and controls is shown
in Table I. There was significant difference between the
blood pressure of cases and controls.
TABLE I Comparison of Anthropometry, Biochemical, Clinical and Imaging Parameters Between Cases and Controls (N=230)
Parameters |
Cases (n=153) |
Controls (n=77) |
P-value |
Birthweight (g) |
1545.5 (243.9) |
2835 (305.8) |
0.214 |
Height (cm) |
162.1 (10.4) |
165.9 (10.2) |
0.009 |
BMI (kg/m2) |
22.3 (4.5) |
21.6 (3.9) |
0.242 |
Waist to hip ratio |
0.83 (0.07) |
0.83 (0.06) |
0.821 |
Sum of 4 skinfolds (mm) |
69.4 (25.1) |
66.9 (29.8) |
0.504 |
Fasting glucose (mg%) |
85.9 (10.0) |
91.0 (7.2) |
0.298 |
30 min glucose (mg%) |
141.9 (27.9) |
145.6 (25.9) |
0.341 |
120 min glucose (mg%) |
108.3 (27.8) |
103.3 (26.2) |
0.195 |
Fasting insulin (mU/L) |
8.0 (2.64-51.91) |
7.4 (0.66-32.20) |
0.117 |
*30 min insulin (mU/L) |
79.8 (5.04-496.20) |
83.4 (21.20-322.74) |
0.715 |
*120 min insulin (mU/L) |
44.1 (5.41-415.39) |
48.2 (11.11-523.86) |
0.984 |
*HOMA-IR |
1.68(0.52-12.16) |
1.67 (0.14-7.39) |
0.349 |
Total cholesterol (mg%) |
143.4 (28.6) |
144.3 (28.8) |
0.828 |
Triglycerides (mg%) |
85.1 (40.3) |
82.6 (40.2) |
0.662 |
HDL cholesterol (mg%) |
40.4 (8.1) |
39.9 (7.3) |
0.658 |
Systolic BP (mm HG) |
113.8 (9.6) |
110.4 (11.7) |
0.024 |
Diastolic BP (mm Hg) |
76.0 (5.2) |
64.3 (7.5) |
0.001 |
*MRI Fat-Mean (mm2) |
112.9 (21.6-372.4) |
124.7 (38.0-329.5) |
0.588 |
HOMA-IR: Homeostatic model assessment-Insulin resistance;
BMI:Body mass index; Values in mean (SD) or *median (IQR). |
Waist circumference
³90 cm in men and
³80 cm in
women was seen in 13 cases (8.5%) and 5 controls (6.5%). Serum
triglycerides ³150
mg/dL (1.7mmol/L) were seen in 13 (8.5%) cases and 4 (5.3%) controls.
Fasting glucose ³110
mg/dL (6.1mmol/L) was seen in 3 (2%) cases and no controls. Blood
pressure ³130/85
mmHg was seen in 12 (7.9%) cases and no controls. High density
lipoprotein £40
mg/dL (1.03 mmol/L) in men and <50mg/dL (1.29 mmol/L) in women was seen
in 109 (71.7%) cases and 55 (72.4%) controls. The difference between
cases and controls in each of these parameters was not significant. The
presence of three components of metabolic syndrome was present in three
cases and no controls (P=0.553). However, two components of
metabolic syndrome were present in 25 (16.4%) cases and 5 (6%) controls
(P=0.039).
Higher BMI at 1, 2, 6, 12, 18 and 22 years correlated
significantly with higher systolic pressure. Higher BMI at 12 years
correlated significantly with higher fasting insulin and HOMA-IR at 22
years. Physical activity and dietary intake was correlated with the
above mentioned parameters, after adjusting for sex and current BMI. The
120-minute insulin level showed inverse correlation with physical
activity. Abdominal obesity determined by MRI estimation was not
significantly different between cases and controls (Table I).
Table II presents the results of multiple
linear regression analysis with 120-minute glucose as the dependent
variable. Sum of four skinfold thickness at 22 years was the significant
and independent determinant of 120-minute glucose. A similar regression
analysis for independent determinants of Homa-IR at 22 years also showed
that sum of four skinfold thickness was a significant determinant (Table
II). Similar results were seen for triglycerides. The 22-year BMI
was a significant independent determinant for blood pressure.
TABLE II Independent Determinants of 120-minutes Glucose and HOMA-R at 22 years
Variable in the model |
Unstandardized Coefficients |
Standardized Coefficient |
P-value |
|
B |
Std. Error |
Beta |
|
120 minutes glucose (Adjusted R2=12.9%) |
|
|
|
|
(Constant) |
125.051 |
38.369 |
— |
0.001 |
Birthweight |
-0.011 |
0.008 |
-0.285 |
0.176 |
Gestational age |
0.236 |
0.980 |
0.029 |
0.810 |
Sex |
-3.642 |
4.375 |
-0.067 |
0.406 |
Sum of skinfolds 22years |
0.341 |
0.074 |
0.343 |
0.001 |
Physical activity level (PAL) |
-7.790 |
10.571 |
-0.055 |
0.462 |
Total calories (Kcal) |
-0.007 |
0.006 |
-0.114 |
0.266 |
SGA / AGA Status |
6.316 |
10.534 |
0.116 |
0.550 |
HOMA-IR (Adjusted R2 = 18.0%) |
|
|
|
|
(Constant) |
0.159 |
0.887 |
— |
0.858 |
Birthweight |
0.000 |
0.000 |
-0.143 |
0.413 |
Gestational age |
-0.004 |
0.023 |
-0.015 |
0.876 |
Sex |
-0.124 |
0.110 |
-0.081 |
0.260 |
Sum of skinfolds 22years |
0.012 |
0.002 |
0.448 |
0.001 |
Physical activity level (PAL) |
0.100 |
0.244 |
0.027 |
0.681 |
Total calories (Kcal) |
0.000 |
0.000 |
0.115 |
0.177 |
SGA / AGA Status |
0.215 |
0.260 |
0.132 |
0.409 |
The birthweight and 22-year weight was divided into
four quartiles. Those who were born small and became big at 22 years
were compared with those who were born small and remained small (Table
III) at 22 years. Fasting, 30 min, 120 min insulin and HOMA-R were
significantly higher in those born small and became big at 22 years.
Serum triglycerides and cholesterol were also higher in this group. They
had higher systolic blood pressure and had more abdominal obesity on MRI
(Table III).
TABLE III Parameters of ‘Small at Birth and Big at 22 Years’ and ‘Small at Birth and Small at 22 Years’ Subjects
Parameters |
Small at birth and Big at 22 years (n= 29) |
Small at birth and small at 22 years (n=35) |
P value |
Fasting glucose (mg%) |
87.0 (8.7) |
84.1 (7.2) |
0.234 |
30 min glucose (mg%) |
142.4 (30.1) |
136.3 (25.9) |
0.476 |
120 min glucose (mg%) |
110.4 (30.9) |
100.9 (22.6) |
0.232 |
Fasting insulin (mU/L) |
10.9 (4.1-51.91) |
6.2 (2.6-10.59) |
0.001 |
*30 min insulin (mU/L) |
154.5 (35.7-396.1) |
60.32 (21.8-251.4) |
0.001 |
*120 min insulin (mU/L) |
53.5 (13.6-415.4) |
37.61 (5.4-144.5) |
0.017 |
*HOMA-IR |
2.33 (0.9-12.2) |
1.19 (0.5-2.5) |
0.001 |
Total cholesterol (mg%) |
154.6 (38.2) |
132.8-21.8 |
0.015 |
Triglycerides (mg%) |
99.3 (43.5) |
67.7 (21.1) |
0.001 |
HDL cholesterol (mg%) |
38.4 (6.6) |
41.1 (8.0) |
0.271 |
Systolic BP (mmHg) |
115.7 (8.9) |
107.4 (9.1) |
0.006 |
Diastolic BP (mmHg) |
77.6 (3.6) |
729 (5.9) |
0.108 |
*MRI Fat-Mean (mm2) |
218.7 (111.9-372.4) |
96.9 (21.6-201.6) |
0.001 |
Values in mean (SD) or *median (IQR). |
There were only six cases of polycystic ovarian
syndrome. None of the females had hirsutism. The preterm AGA and SGA
cases were compared for all biochemical parameters and blood pressure
and MRI fat (Web Table I). There was no difference in any
of the parameters, except for systolic blood pressure.
The BMI of both mother and father was compared
separately with that of the cases and controls. The BMI of parents
correlated with BMI of the study group. When the incidence of the five
components of Met-S between those having family history of diabetes and
cardiovascular disease and those not having a family history was
compared, there was no significant difference. During our study, six
parents were found to be prediabetic, two were frank diabetic and five
parents had hypertension, and were not aware of it.
Discussion
This study showed that the prevalence of three
components of metabolic syndrome was low at 22 years in LBW children.
However, when only two components were concerned, there was a
significant difference between their occurrence in cases and controls,
hypertension being the first component to appear. The study also showed
that ‘small at birth and big at 22 years’ had many adverse effects like
hypertension, increased cholesterol and triglycerides, increased insulin
levels and insulin resistance, and increased abdominal obesity. Sum of
skinfold thickness at 22 years was an independent determinant of
120-minute glucose, insulin resistance and triglycerides.
This is the last phase of a long prospective study
spanning 22 years. In order to enroll the 22-year-old subjects, we
offered a free check-up for parents as an added incentive. The dietician
could assess the diet of the family and give advice regarding
appropriate diet. The main limitation of this study was the less number
of controls compared to the cases.
We had earlier studied these subjects for central
obesity by taking all their anthropometric measurements for adiposity at
18 years, and found no evidence of adiposity [5]. There are several
reports that Asians have normal BMI, but have excess deposition of fat
around the waist [14]. The Rancho Bernardo study [16] showed that low
birth weight coupled with adult obesity is a strong determinant of
metabolic syndrome in postmenopausal women. We found that BMI at 12, 18
and 22 years significantly correlated with higher insulin and HOMA-IR.
Sachdev, et al. [16] reported that serial measurements of
childhood BMI give useful prediction regarding risk of developing
adultmetabolic syndrome. Higher BMI at 1, 2, 6 and 18 and 22 years
correlated with higher systolic blood pressure in our study. A lot of
stress has been placed on BMI in many of the studies on the metabolic
syndrome, but very little attention has been given to measurements of
adiposity. Dalleck, et al. [17] found that waist circumference
was independently associated with HDL cholesterol. We found sum of four
skinfold thicknesses to be relatively a stronger correlate for
biochemical parameters as well as blood pressure compared to BMI, waist
circumference and MRI estimation of subcutaneous abdominal fat. A simple
measurement of adiposity such as sum of four skinfold thickness may be
sufficient, compared to a time consuming and expensive measurement like
MRI. Lloyd, et al. [18] carried out a meta-analysis of all
studies that linked childhood obesity with risk of developing metabolic
syndrome. They also reported that there is a little evidence to suggest
that greater BMI in childhood was an independent factor for dyslipidemia
in adulthood.
We found that "small at birth and big at 22 years"
had higher insulin levels and high HOMA-IR. A study from Denmark [19]
showed that weight gain in first 3 months of life may increase the risk
of metabolic syndrome, particularly glucose metabolism in SGA children.
A large study from China [20] reported several components of metabolic
syndrome presenting in LBW children in late adulthood. Bavdekar, et
al. [21] reported "small at birth and big at 8 years" to have
impaired glucose tolerance test. Although we had very few cases with
three components to meet the IDF criteria of Metabolic Syndrome, the LBW
cases had a higher number of two components compared to controls at 22
years. Our findings suggestive of early onset of trends of meatbolic
syndrome need further study and reassessment again after a few years.
However, it definitely points out the need to initiate early
interventions of dietary and lifestyle influences.
Contributors: SC: conceived and carried
out the study and wrote the manuscript and shall be guarantor for the
paper; MO: helped in data collection and counseling of the family; MH:
was responsible for getting the patients and collecting blood samples;
AP: supervised the project; MS: statistical analysis. All authors
contributed to manuscript writing and its approval.
Funding: Indian Council of Medical Research, New
Delhi, India. Grant No. 5/4/8-7/2009-NCD-II.
Competing interest: None stated.
What is Already Known?
• Low birth weight children develop metabolic
syndrome in adulthood, especially small for gestational age
infants.
What This Study Adds?
• Components of metabolic syndrome at 22
years of age are more common among those born low birth weight.
• Those small at birth and big at 22 years
had higher frequency of insulin resistance.
|
References
1. Ramachandran A, Snehalatha C, Latha E, Vijay V,
Viswanathan M. Rising prevalence of NIIDM in an urban population in
India. Diabetologia. 1997;40:232-7.
2. Barker DJP. Foetal origins of coronary heart
disease. BMJ. 1995;311:171-4.
3. Reddy KS. Cardiovascular diseases in India. World
Health Stat. 1993;46:101-7.
4. Sachdev HPS. Nutritional transition in the
backdrop of the early life origins of adult disease: a challenge for the
future. Indian J Med Res. 2004;119:iii-v.
5. Chaudhari S, Otiv M, Khairnar B, Pandit A, Hoge M,
Sayyad M. Pune low birth weight study – Growth from birth to adulthood.
Indian Pediatr. 2012;49:727-32.
6. Chaudhari S, Otiv M, Khairnar B, Pandit N, Hoge M,
Sayyad M. Pune low birth weight study-Birth to adulthood – cognitive
development. Indian Pediatr. 2013;50:853-7.
7. Singh M. Care of the Newborn. 4th ed. New Delhi:
Sagar Publications, 1979.
8. Tanner JM. Normal growth and techniques of growth
assessment. Cl Endocr and Metab. 1986;3:411-51.
9. Gopalan C, Rama Shashtri BV, Balsbramanian SC.
Nutritive Value of Indian Foods. National Institute of Nutrition, Indian
Council of Medical Research, 2002.
10. Kurpad AV, Swaminathan S, Bhat S. IAP National
Task Force for Childhood Prevention of Adult Diseases: the effect of
childhood physical activity on prevention of adult diseases. Indian
Pediatr. 2004;41:37-62.
11. Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E,
Chassidim Y, et. al. Abdominal superficial subcutaneous fat: A
putative distinct protective far subdepot in Type 2 diabetes. Diabetes
Care. 2012;35:640-7.
12. Rumack CM, Wilson SR, Charboneau JW. Diagnostic
Ultrasound. Vol I, 2nd ed. Mosby 1998. P. 313.
13. The IDF Consensus Worldwide Definition of the
Metabolic Syndrome Available from :https://www.idf.org/webdata/docs/IDF_Meta_def_Final.pdf.
14. Mishra A, Khurana L. Obesity and the metabolic
syndrome in developing countries. J Clin Endocrinol Metab.
2008;93:509-25.
15. Yarbrough D, Barrott ConnorE, Krietz Silverstein,
Wingard DL. Birth weight, adult weight, and girth as predictors of
metabolic syndrome in postmenopausal women: the Rancho Bernardo Study.
Diabetes Care.1998;21:1652-8.
16. Sachdev HP, Osmond C, Fall CH, Lakshmy R, Ramji
S, Dey Biswas SK, et. al. Predicting adult metabolic syndrome
from childhood body mass index: follow-up of the New Delhi cohort. Arch
Med Res. 2008;39:796-802.
17. Dalleck LC, Kiellan EM. The prevalence of
metabolic syndrome and metabolic syndrome risk factors in college-aged
students. Am J Health Promot. 2012;27:37-42.
18. Lloyd LJ, Langley-Evans, McMuellen S. Childhood
obesity a risk of adult metabolic syndrome: a systematic review. Intl J
Obesity. 2012;36:1-11.
19. Fabricius-Bjerre S, Jensen RB, Færch K, Larsen
T, Mølgaard C, Michaelsen KF, et al. Impact of birth
weight and early infant weight gain on insulin resistance and associated
cardiovascular risk factors in adolescence. PLoS One. 2011;6:e20595.
20. Xiao X, Zhang ZX, Li WH, Feng K, Sun Q, Cohen
HJ, et al. Low birth weight is associated with components of the
metabolic syndrome. Metabolism. 2010;59:1282-6.
21. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V
et. al. The insulin resistance (IRS) in eight year old Indian
children: small at birth big at 8 years or both? Diabetes.
2000;48:2422-8.
|
|
 |
|